Third-generation chimeric antigen receptor (CAR) T cells in patients with lymphoid disease - results of the Heidelberg trial 1 (HD-CAR-1 trial)

被引：0
|
作者：
Schubert, M. L. [1 ]
Schmitt, A. [1 ]
Neuber, B. [1 ]
Hueckelhoven-Krauss, A. [1 ]
Kunz, A. [1 ]
Wang, L. [1 ]
Michels, B. [1 ]
Waldhoff, P. [1 ]
Sellner, L. [1 ,2 ]
Korell, F. [1 ]
Hofmann, S. [1 ]
Pavel, P. [3 ]
Ho, A. D. [1 ,2 ]
Mueller-Tidow, C. [1 ,2 ]
Dreger, P. [1 ,2 ]
Schmitt, M. [1 ,2 ]
机构：
[1] Univ Klinikum Heidelberg, Innere Med 5, Heidelberg, Germany
[2] Deutsch Krebsforschungszentrum DKFZ, Deutsch Konsortium Translat Krebsforsch DKTK, Natl Ctr Tumorerkrankungen NCT, Heidelberg, Germany
[3] DRK Blutspendedienst Baden Wurttemberg Hessen, Inst Klin Transfus Med & Zelltherapie IKTZ, Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V318
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [41] Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
    Qi, Changsong
    Liu, Chang
    Gong, Jifang
    Liu, Dan
    Wang, Xicheng
    Zhang, Panpan
    Qin, Yanru
    Ge, Sai
    Zhang, Miao
    Peng, Zhi
    Zhou, Jun
    Lu, Zhihao
    Lu, Ming
    Cao, Yanshuo
    Yuan, Jiajia
    Wang, Yakun
    Wang, Zhenghang
    Xue, Ran
    Peng, Xiaohui
    Wang, Yumeng
    Yuan, Daijing
    Li, Jian
    Zhang, Xiaotian
    Shen, Lin
    NATURE MEDICINE, 2024, 30 (08) : 2224 - 2234
  • [42] A phase 1 trial of TLR2-costimulated third-generation anti-CD19 CAR T-cells for relapsed/refractory B non-Hodgkin lymphomas
    Weinkove, Robert
    George, Philip
    Fyfe, Robbie
    Nouri, Yasmin
    Dasyam, Nathaniel
    Ostapowicz, Tess
    Mester, Brigitta
    Giunti, Giulia
    Perera, Travis
    Jina, Hayden
    D'Souza, Alwyn
    Perret, Rachel
    Li, Peng
    Hermans, Ian
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 8 - 9
  • [43] A simple and effective method to purify and activate T cells for successful generation of chimeric antigen receptor T (CAR-T) cells from patients with high monocyte count
    Wang, Haiying
    Tsao, Shih-Ting
    Gu, Mingyuan
    Fu, Chengbing
    He, Feng
    Li, Xiu
    Zhang, Mian
    Li, Na
    Hu, Hong-Ming
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [44] GENETICALLY ENGINEERED INDUCED PLURIPOTENT STEM CELLS (IPSC) FOR THE EFFICIENT GENERATION OF HYPOIMMUNOGENEIC CHIMERIC ANTIGEN RECEPTOR (CAR)-ENGINEERED T CELLS
    Nianias, Alexandros
    Katsarou, Afroditi
    Prins, Henk-Jan
    Shahrabi, Aida
    van Velzen, Cindy
    Groen, Richard
    Mutis, Tuna
    Themeli, Maria
    EXPERIMENTAL HEMATOLOGY, 2022, 111 : S118 - S118
  • [45] Phase 1 trial of anti-CD19 chimeric antigen receptor T (CAR-T) cells with tumor necrosis alfa receptor superfamily 19 (TNFRSFI9) transmembrane domain.
    Caimi, Paolo Fabrizio
    Reese, Jane
    Otegbeye, Folashade
    Schneider, Dina
    Chamoun, Kamal
    Boughan, Kirsten M.
    Cooper, Brenda W.
    Galloway, Erin
    Gallogly, Molly
    Kruger, Winfried
    Worden, Andrew
    Kadan, Michael
    Malek, Ehsan
    Metheny, Leland L.
    Tomlinson, Benjamin K.
    Sekaly, Rafick-Pierre
    Wald, David
    Orentas, Rimas
    Dropulic, Boro
    De Lima, Marcos J. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] A Cancer Research UK phase I trial of anti-GD2 chimeric antigen receptor (CAR) transduced T-cells (1RG-CART) in patients with relapsed or refractory neuroblastoma
    Straathof, Karin
    Flutter, Barry
    Wallace, Rebecca
    Thomas, Simon
    Cheung, Gordon
    Collura, Angela
    Gileadi, Talia
    Barton, Jack
    Wright, Gary
    Inglott, Sarah
    Edwards, David
    Barton, Claire
    Dyer, Karen
    Westwood, Nigel
    Loka, Thalia
    Depani, Sarita
    Howe, Karen
    Barone, Giuseppe
    Pule, Martin
    Anderson, John
    CANCER RESEARCH, 2018, 78 (13)
  • [47] Hematologists’ barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study
    Gisell Castillo
    Manoj Lalu
    Sarah Asad
    Madison Foster
    Natasha Kekre
    Dean Fergusson
    Terry Hawrysh
    Harold Atkins
    Kednapa Thavorn
    Joshua Montroy
    Stuart Schwartz
    Robert Holt
    Raewyn Broady
    Justin Presseau
    Trials, 22
  • [48] Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study
    Castillo, Gisell
    Lalu, Manoj
    Asad, Sarah
    Foster, Madison
    Kekre, Natasha
    Fergusson, Dean
    Hawrysh, Terry
    Atkins, Harold
    Thavorn, Kednapa
    Montroy, Joshua
    Schwartz, Stuart
    Holt, Robert
    Broady, Raewyn
    Presseau, Justin
    TRIALS, 2021, 22 (01)
  • [49] Gene-knocked out chimeric antigen receptor (CAR) T cells: Tuning up for the next generation cancer immunotherapy
    Mirzaei, Hamid Reza
    Pourghadamyari, Hossein
    Rahmati, Majid
    Mohammadi, Abbas
    Nahand, Javid Sadri
    Rezaei, Abbas
    Mirzaei, Hamed
    Hadjati, Jamshid
    CANCER LETTERS, 2018, 423 : 95 - 104
  • [50] Absence of CD39 on chimeric antigen receptor (CAR) T cells is predictive for response in adult ALL patients
    Schubert, M. L.
    Schmitt, A.
    Huckelhoven-Krauss, A.
    Neuber, B.
    Waldho, P.
    Vonficht, D.
    Yousefian, S.
    Jopp-Saile, L.
    Korell, F.
    Haas, S.
    Ho, A. D.
    Mueller-Tidow, C.
    Dreger, P.
    Schmitt, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 37 - 37
12345